1. Home
  2. PKE vs DCTH Comparison

PKE vs DCTH Comparison

Compare PKE & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PKE
  • DCTH
  • Stock Information
  • Founded
  • PKE 1954
  • DCTH 1988
  • Country
  • PKE United States
  • DCTH United States
  • Employees
  • PKE N/A
  • DCTH N/A
  • Industry
  • PKE Military/Government/Technical
  • DCTH Medical/Dental Instruments
  • Sector
  • PKE Industrials
  • DCTH Health Care
  • Exchange
  • PKE Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • PKE 378.7M
  • DCTH 388.3M
  • IPO Year
  • PKE N/A
  • DCTH N/A
  • Fundamental
  • Price
  • PKE $18.69
  • DCTH $10.84
  • Analyst Decision
  • PKE
  • DCTH Strong Buy
  • Analyst Count
  • PKE 0
  • DCTH 4
  • Target Price
  • PKE N/A
  • DCTH $24.50
  • AVG Volume (30 Days)
  • PKE 93.7K
  • DCTH 473.5K
  • Earning Date
  • PKE 10-14-2025
  • DCTH 11-07-2025
  • Dividend Yield
  • PKE 2.62%
  • DCTH N/A
  • EPS Growth
  • PKE 4.18
  • DCTH N/A
  • EPS
  • PKE 0.34
  • DCTH 0.06
  • Revenue
  • PKE $63,456,000.00
  • DCTH $70,240,000.00
  • Revenue This Year
  • PKE N/A
  • DCTH $159.22
  • Revenue Next Year
  • PKE N/A
  • DCTH $41.22
  • P/E Ratio
  • PKE $56.21
  • DCTH $193.39
  • Revenue Growth
  • PKE 16.60
  • DCTH 491.35
  • 52 Week Low
  • PKE $11.97
  • DCTH $8.08
  • 52 Week High
  • PKE $20.73
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • PKE 52.44
  • DCTH 45.67
  • Support Level
  • PKE $18.20
  • DCTH $11.01
  • Resistance Level
  • PKE $19.29
  • DCTH $11.93
  • Average True Range (ATR)
  • PKE 0.61
  • DCTH 0.44
  • MACD
  • PKE -0.07
  • DCTH 0.05
  • Stochastic Oscillator
  • PKE 34.75
  • DCTH 18.05

About PKE Park Aerospace Corp.

Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: